Drug Application Partner
Accelerate Your Drug Development Timeline to NDA
Looking to accelerate your drug candidates' development timeline to the New Drug Application (NDA) stage? Quotient Sciences experts can help shorten your drug development program.
At Quotient Sciences we understand that getting molecules to proof-of-concept (POC) is a key milestone in the development of a new drug candidate. We offer fully integrated capabilities. From first-in-human testing to seamless drug product supply for patient trials, we operate a cost-effective process that accelerates molecules through to POC and NDA.
Accelerating Early Candidate Development
POC to NDA Partner
From your molecule discovery to proof-of-concept (POC) to New Drug Application (NDA), Quotient Sciences are well equipped to partner with you to accelerate your drug approval process.
We have many years of success at simplifying the early development to proof-of-concept of molecules, a key milestone in the development of a new drug candidate. At the same time, we also understand the transition to POC needs to be fast and cost-effective.
Contact our experts
Quotient Sciences can help address the most critical challenges in the drug development process from proof-of-concept to new drug application. Contact us today to learn how we can help accelerate your program.
Molecule to cure. Fast.
-
Accelerating TimelinesAccelerate your path to the clinic with Charles River & Quotient SciencesIntegrated strategies for accelerating from discovery to IND. Introducing the Charles River and Quotient Sciences Collaboration.
-
Integrated ProgramsTranslational Pharmaceutics®Quotient Sciences' own Translational Pharmaceutics® solution innovates the way you design and implement your drug development program.